Signaling pathways
-
BA8165 PF-05085727Summary: PF-05085727 is a potent cGMP-dependent (=2nM) selective and brain permeable inhibitor. - BA8166 TovinontrineSummary: Tovinontrine (IMR-687) is a potent and selective phosphodiesterase 9 inhibitor for the study of sickle cell disease.
- BA8167 CudetaxestatSummary: A potent, orally active inhibitor.
- BA8168 PDE4B-IN-3Summary: PDE4B-IN-3 is a potent inhibitor.
- BA8169 VesnarinoneSummary: Vesnarinone (OPC-8212) is an orally active inhibitor.
- BA8170 TP-10Summary: TP-10 is a selective PDE10A inhibitor.
- BA8171 Enpp-1-IN-12Summary: Enpp-1-IN-12 is a potent and orally active ectonucleotide pyrophosphatase/phosphodiesterase 1 inhibitor with a value of 41nM.
- BA8172 PDE1-IN-2Summary: PDE1-IN-2 is a phosphodiesterase inhibitor.
- BA8173 PF-04449613Summary: PF-04449613 is a selective inhibitor of 22 nM.
- BA8174 ONO-8430506Summary: ONO-8430506 is a potent, orally active inhibitor of ATX activity in mouse plasma.